Correlation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC)
cytuj
pobierz pliki
RIS BIB ENDNOTEWybierz format
RIS BIB ENDNOTECorrelation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC)
Data publikacji: 29.12.2022
Problems of Forensic Sciences (Z Zagadnień Nauk Sądowych), 2022, 130-131, s. 157 - 168
https://doi.org/10.4467/12307483PFS.22.009.16818Autorzy
Correlation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC)
The impact of marijuana on road safety has been the subject of many debates over the years. These debates have intensified in recent years due to initiatives carried out in several jurisdictions aimed at marketing medical cannabis. According to Polish forensic toxicologists, road safety is a key issue, especially following the conferences in November 2012 in Kraków and in 2013 in Augustów (Gieroń et al., 2013), Poland, on the determination of appropriate concentration thresholds. These thresholds, defining the limit for the ‘after use’ and ‘under the influence’ conditions, are still not unambiguous or easy to determine for the Polish government. An unambiguous assessment of the impact of a given concentration of blood THC on psychomotor performance is very difficult, and will remain so in the foreseeable future. This study used 107 randomly selected blood collection protocols, with 10 protocols for each THC concentration ranging from 1 to 10 ng/ml, on the basis of which thirteen features related to the external appearance and behaviour of the tested individuals were analysed. These features were: facial skin (pale, normal or red), slurred speech, mood and behaviour (cheerful, talkative, rowdy or reticent), heart rate, pupils (normal, dilated or contracted), reaction of pupils to light, the Romberg test, the finger-to-nose test, picking up objects from the ground and awareness of time and place. Five of the thirteen features related to the appearance and behaviour of the respondents showed no abnormalities (gait, the Romberg test, the finger-to-nose test, picking up objects from the ground, and awareness of time and place). The study found that the symptoms observed and recorded in the protocols are insufficient to make a decision about the impact of THC on psychomotor performance. The characteristic symptoms (cheerfulness and talkativeness) occurred no more frequently than in 3 out of 10 of the concentrations tested.
1. Arkell, T. R., Vinckenbosch, F., Kevin, R. C., Theunissen, E. L., McGregor, I. S., Ramaekers, J. G. (2020). Effect of cannabidiol and Δ9-tetrahydrocannabinol on driving performance. A randomized clinical trial. JAMA, 324(21), 2177–2186.
2. Bolla, K. I., Brown, K., Eldreth, D., Tate, K., Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59, 1337–1343.
3. Crean, R. D., Crane, N. A., Mason, B. J. (2011). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of Addiction Medicine, 5(1), 1–8. 4. DRUID (2022). Meta-analysis of empirical studies concerning the effects of medicines and illegal drugs including pharmacokinetics on safe driving. Project No. TRE N-05-FP6TR-S07.61320-518404-DRUID. Retrieved May 10, 2022 from: https://www.bast.de/Druid/EN/deliverales-list/deliverables-list-node.html.
5. Gieroń, J., Adamowicz, P., Gil, D., Tokarczyk, B., Skulska, A., Lechowicz, W. (2013). Interpretacja wyników oznaczania THC oraz THCCOOH we krwi kierowców – dane z praktyki IES z lat 2010–2013 i projektu DRUID. (In) M. Kała, D. Zuba (Eds.), XXX Konferencja Toksykologów Sądowych „Środki podobnie działające do alkoholu w praktyce toksykologa sądowego”, Augustów, 15–17 maja 2013. Materiały konferencyjne (pp.19–20). Kraków: Wydawnictwo Instytutu Ekspertyz Sądowych.
6. Gorelick, D. A., Goodwin, R. S., Schwilke, E., Schwope, D. M., Darwin, W. D., Kelly D. L., McMahon, R. P., Liu, F., Ortemann-Renon, C., Bonnet, D., Huestis, M. A. (2013). Tolerance to effects of high-dose oral Δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicolology, 37(1), 11–16.
7. Lechowicz, W., Adamowicz, P., Bakalarz, D., Gil, D., Gieroń, J., Skulska, A., Tokarczyk, B. (2017). Estimating the change in concentration of THC in the blood of drivers over the time between stopping and collection of blood for testing. Problems of Forensic Sciences, 110, 97–109.
8. Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits: What is the nature of the association? Drug and Alcohol Dependance, 69, 303–310.
9. Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58(10), 909–915.
10. Pope, H. G., Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. JAMA, 275, 521–527.
11. Preuss, U. W., Huestis, M. A., Schneider, M., Hermann, D., Lutz, B., Hasan, A., Kambeitz, J., Wong, J. W. M., Hoch, E. (2021). Cannabis use and car crashes: A review. Frontiers in Psychiatry, 12, 643315.
12. Ramaekers, J. G. (2006). Commentary on cannabis and crash risk: concentration effect relation. Transportation Research E-Circular, E-C096, 65–66.
13. Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., Moeller, M. R. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23, 266–277.
14. Ramaekers, J. G., Mason, N. L., Kloft, L., Theunissen, E. L. (2021). The why behind the high: determinants of neurocognition during acute cannabis exposure. Nature Review Neuroscience, 22(7), 439–454.
15. Ramaekers, J. G., Moeller, M. R., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., Kauert, G. (2006). Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug and Alcohol Dependance, 85(2), 114–122.
16. Raport EMCDDA 2021;. Retrieved September 20, 2022 from: https://www.emcdda.europa.eu/system/files/publications/13838/2021.2256_PL_03.pdf.
17. Rogeberg, O. (2019). A meta-analysis of the crash risk of cannabis-positive drivers in culpability studies — Avoiding interpretational bias. Accident Analysis & Prevention, 123, 69–78.
18. Rozporządzenie Ministra Zdrowia z dnia 11 czerwca 2003 r. w sprawie wykazu środków działających podobnie do alkoholu oraz warunków i sposobu przeprowadzania badań na ich obecność w organizmie (2003). Dziennik Ustaw, 116, 1104.
19. Rozporządzenie Ministra Zdrowia z dnia 11 marca 2004 r. zmieniające rozporządzenie w sprawie wykazu środków działających podobnie do alkoholu oraz warunków i sposobu przeprowadzania badań na ich obecność w organizmie (2004). Dziennik Ustaw, 52, 524.
20. Rozporządzenie Ministra Zdrowia z dnia 16 lipca 2014 r. w sprawie wykazu środków działających podobnie do alkoholu oraz warunków i sposobu przeprowadzania badań na ich obecność w organizmie (2014). Dziennik Ustaw, 948.
21. Schwope, D. M., Bosker, W. M., Ramaekers, J. G., Gorelick, D. A., Huestis, M. A. (2012). Psychomotor performance, subjective and physiological effects and whole blood Δ-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. Journal of Analytical Toxicolology, 36(6), 405–412.
22. Solowij, N. (2002). Marijuana Treatment Project Research Group, cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA, 287, 1123–1131.
23. Solowij, N., Battisti, R. (2008). The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews, 1, 81–98.
24. Ustawa z dnia 26 października 1982 r. o wychowaniu w trzeźwości i przeciwdziałaniu alkoholizmowi (1982). Dziennik Ustaw, 5, 230.
25. World Health Organization (2022). ICD-11 for Mortality and Morbidity Statistics (MMS) 2022-02. Retrieved May 10, 2022 from: https://icd.who.int/en
26. Wyrok Sądu Najwyższego, sygn. akt II KK 219/14 (2014).
Informacje: Problems of Forensic Sciences (Z Zagadnień Nauk Sądowych), 2022, 130-131, s. 157 - 168
Typ artykułu: Oryginalny artykuł naukowy
Tytuły:
Correlation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC)
Correlation of symptoms registered during blood collection from drivers who tested positive for Δ9-tetrahydrocannabinol (THC)
Instytut Ekspertyz Sądowych im. Prof. dra Jana Sehna w Krakowie, Kraków
Instytut Ekspertyz Sądowych im. Prof. dra Jana Sehna w Krakowie, Kraków
Publikacja: 29.12.2022
Otrzymano: 23.08.2022
Zaakceptowano: 13.09.2022
Status artykułu: Otwarte
Licencja: CC BY-NC-ND
Udział procentowy autorów:
Korekty artykułu:
-Języki publikacji:
Angielski, PolskiLiczba wyświetleń: 549
Liczba pobrań: 429
Sugerowane cytowania: Vancouver